Nerve growth factor for the treatment of spinocerebellar ataxia type 3: an open-label study.
Tan S, Wang RH, Niu HX, Shi CH, Mao CY, Zhang R, Song B, Sun SL, Liu XJ, Hou HM, Liu YT, Gao Y, Fang H, Kong XD, Xu YM.
Tan S, et al. Among authors: fang h.
Chin Med J (Engl). 2015 Feb 5;128(3):291-4. doi: 10.4103/0366-6999.150087.
Chin Med J (Engl). 2015.
PMID: 25635421
Free PMC article.